HK Stock MarketDetailed Quotes

02616 CSTONE PHARMA-B

Watchlist
  • 1.990
  • 0.0000.00%
Not Open Nov 21 18:11 CST
2.56BMarket Cap-16446P/E (TTM)

About CSTONE PHARMA-B Company

Cornerstone Pharmaceuticals was created to meet the needs of cancer patients, focusing on the development and commercialization of innovative tumor immunotherapy and molecular targeted drugs. Since its establishment 3 years ago, the company has assembled a world-class management team and has rich experience in pre-clinical research, clinical development and commercialization. Through a dual source of innovation composed of internal R&D and external cooperation, the company has built a strong anti-tumor drug pipeline with 14 drug candidates, including 4 exclusive cooperation and authorized products between Blueprint Medicine and Agios Pharmaceuticals, which together with the self-developed pipeline have significant potential and synergy effects for single and combination therapies. Of the drug candidates under development, 4 are in or near critical testing. Cornerstone Pharmaceuticals' business model is driven by clinical research and development, while rapidly establishing commercialization and production capacity. The company received support from well-known investors, and the amount of round A and B financing both broke records in the biomedical field at the time. The total amount of the two rounds of financing was 0.412 billion US dollars. With an experienced team, a promising R&D pipeline, a strong business model, and sustainable financial support, Cornerstone's vision is to become a world-renowned leading Chinese biopharmaceutical company by bringing innovative and differentiated oncology therapies to cancer patients around the world.

Company Profile

Symbol02616
Company NameCSTONE PHARMA-B
ISINKYG2588M1006
Listing DateFeb 26, 2019
Issue Price12.00
Shares Offered186.40M share(s)
FoundedDec 2, 2015
Registered AddressCayman Islands
Chairmanwei li
Secretaryweicongwengmeiyi ni
Audit InstitutionDeloitte Guan Huang Chen Fang Certified Public Accountants
Company CategoryOther
Registered OfficeVistra (Cayman) Limited Office P.O. Box 31119 Grand Pavilion Hibiscus Way 802 West Bay Road Grand Cayman KY1-1205 Cayman Islands
Head Office and Principal Place of Business40th Floor, Dah Sing Finance Centre, 248 Queen's Road East, Wan Chai, Hong Kong
Fiscal Year Ends12-31
Employees164
MarketHong Kong motherboard
Phone(86)(0)21 61097678
Fax(021)61097689
Emailir@cstonepharma.com
Business Cornerstone Pharmaceuticals is a Chinese investment holding company. The company is mainly engaged in R&D, production and sales of biopharmaceutical products through its subsidiaries. The company's main products are tumor immunotherapy treatments and molecular-targeted drugs. The company mainly operates within China.

Company Executives

  • Name
  • Position
  • Salary
  • jianxin yang
  • CEOs, Executive Director, Chairman of the Strategy Committee, Authorized Representative
  • --
  • wei li
  • Presidencies, Non-executive Directors, Chairman of the Nomination Committee, Remuneration Committee Members
  • --
  • Kenneth Walton Hitchner III
  • Non-executive Directors
  • --
  • xianghong lin
  • Non-executive Directors
  • --
  • zhengguo hu
  • Non-executive Directors, Strategy Committee Members
  • --
  • Paul Herbert Chew
  • Independent Non-Executive Director, Audit Committee Members, Strategy Committee Members, Nomination Committee Members, Remuneration Committee Members
  • --
  • dingxu hu
  • Independent Non-Executive Director, Remuneration Committee Chairman, Nomination Committee Members, Audit Committee Members
  • --
  • hongbin sun
  • Independent Non-Executive Director, Chairman of the Audit Committee, Nomination Committee Members
  • --
  • qingmei shi
  • Senior Vice President, Chief Medical Officer
  • --
  • yujuan la
  • Senior Vice President of Product Development
  • --
  • Michael J. Choi
  • Chief Business and Strategy Officer
  • --
  • min liao
  • VP, Head of the Department of Commerce
  • --
  • weicong ni
  • Joint Company Secretary
  • --
  • yinghua zhang
  • Senior Vice President, Head of Operations
  • --
  • meiyi weng
  • Joint Company Secretary, Authorized Representative
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data